Related Experiment Videos

The approach to the treatment of secondary hyperparathyroidism in early renal failure

A Fournier¹, P Morinière, H Renaud

¹Department of Nephrology, CHU Amiens, France.

American Journal of Nephrology

|January 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.

The Journal of pharmacology and experimental therapeutics·1992

Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.

The Journal of pharmacology and experimental therapeutics·1992

Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.

The Journal of pharmacology and experimental therapeutics·1992

Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

Brain research·1992

Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

Kidney international·1992

Immunohistochemical distribution and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda.

The Journal of comparative neurology·1992

See all related articles